Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 0.44% is 100% above its 5-year average of -161.81%, near the high end of its 5-year range (-534.01%–2.43%).
As of the fiscal period ended Tuesday, June 30, 2026. 66.39% below its 12-month average of 1.31%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 0.44%.
RETURN ON EQUITY (ROE)
0.44%
RETURN ON EQUITY (ROE) AVG TTM
1.31%
RETURN ON EQUITY (ROE) AVG 3Y
-116.30%
RETURN ON EQUITY (ROE) AVG 5Y
-161.81%
RETURN ON EQUITY (ROE) AVG 10Y
-166.94%
RETURN ON EQUITY (ROE) AVG 15Y
-144.13%
RETURN ON EQUITY (ROE) AVG 20Y
-123.93%
CURRENT VS TTM AVG
-66.39%
CURRENT VS 3Y AVG
+100.38%
CURRENT VS 5Y AVG
+100.27%
CURRENT VS 10Y AVG
+100.26%
CURRENT VS 15Y AVG
+100.30%
CURRENT VS 20Y AVG
+100.35%
SECTOR MEDIAN · HEALTHCARE
-36.00%
median of 392 covered companies
CURRENT VS SECTOR MEDIAN
+101.22%
vs the sector median at left
Delcath Systems, Inc.
Market Cap
$547.86M
Return on Equity (ROE)
0.44%
TTM Avg
1.31%
3Y Avg
-116.30%
5Y Avg
-161.81%
Market Cap
$551.09M
Return on Equity (ROE)
-17.44%
TTM Avg
-97.25%
3Y Avg
-87.77%
5Y Avg
-77.06%
Market Cap
$561.67M
Return on Equity (ROE)
-26.37%
TTM Avg
-3503.18%
3Y Avg
-1722.33%
5Y Avg
3198.08%
Market Cap
$569.56M
Return on Equity (ROE)
40.62%
TTM Avg
9.52%
3Y Avg
-25.24%
5Y Avg
-32.61%
Market Cap
$573.38M
Return on Equity (ROE)
N/A
TTM Avg
161.13%
3Y Avg
93.89%
5Y Avg
96.07%
Market Cap
$519.25M
Return on Equity (ROE)
-19.35%
TTM Avg
-58.07%
3Y Avg
-51.86%
5Y Avg
-46.32%
Market Cap
$517.79M
Return on Equity (ROE)
-99.83%
TTM Avg
118.83%
3Y Avg
8.21%
5Y Avg
-14.12%
Market Cap
$517.73M
Return on Equity (ROE)
-37.94%
TTM Avg
-63.13%
3Y Avg
-60.30%
5Y Avg
-47.34%
Market Cap
$579.88M
Return on Equity (ROE)
N/A
TTM Avg
44.05%
3Y Avg
44.05%
5Y Avg
44.05%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Delcath Systems, Inc. (DCTH) | $547.86M | 0.44% | 1.31% | -116.30% | -161.81% |
| Immix Biopharma, Inc. (IMMX)vs › | $551.09M | -17.44% | -97.25% | -87.77% | -77.06% |
| CytomX Therapeutics, Inc. (CTMX)vs › | $561.67M | -26.37% | -3503.18% | -1722.33% | 3198.08% |
| CorMedix Inc. (CRMD)vs › | $569.56M | 40.62% | 9.52% | -25.24% | -32.61% |
| Aquestive Therapeutics, Inc. (AQST)vs › | $573.38M | N/A | 161.13% | 93.89% | 96.07% |
| Altimmune, Inc. (ALT)vs › | $519.25M | -19.35% | -58.07% | -51.86% | -46.32% |
| Crescent Biopharma, Inc. (CBIO)vs › | $517.79M | -99.83% | 118.83% | 8.21% | -14.12% |
| Allogene Therapeutics, Inc. (ALLO)vs › | $517.73M | -37.94% | -63.13% | -60.30% | -47.34% |
| BlossomHill Therapeutics, Inc. (BLSM)vs › | $579.88M | N/A | 44.05% | 44.05% | 44.05% |
| Aclaris Therapeutics, Inc. (ACRS)vs › | $596.36M | -60.79% | -73.94% | -62.04% | -71.62% |
ROE
0.4%
ROA
0.4%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 0.44% |
| 2026-03-31 | 0.50% |
| 2025-12-31 | 2.43% |
| 2025-09-30 | 1.04% |
| 2025-06-30 | 2.13% |
| 2025-03-31 | -17.71% |
| 2024-12-31 | -38.38% |
| 2024-09-30 | -398.13% |
| 2024-03-31 | -340.55% |
| 2023-12-31 | -302.20% |
| 2023-09-30 | -188.86% |
| 2022-03-31 | -534.01% |
| 2021-12-31 | -214.60% |
| 2021-09-30 | -233.08% |
| 2021-06-30 | -166.22% |
| 2021-03-31 | -115.18% |
| 2020-12-31 | -109.41% |
| 2020-09-30 | -141.48% |
| 2020-06-30 | -93.00% |
| 2016-09-30 | -324.97% |
| 2016-06-30 | -294.57% |
| 2016-03-31 | -165.78% |
| 2015-12-31 | -170.93% |
| 2015-09-30 | -92.89% |
| 2015-06-30 | -112.04% |
| 2015-03-31 | -94.93% |
| 2014-12-31 | -95.79% |
| 2014-09-30 | -92.95% |
| 2014-06-30 | -86.87% |
| 2014-03-31 | -76.75% |
| 2013-12-31 | -100.75% |
| 2013-09-30 | -129.80% |
| 2013-06-30 | -123.42% |
| 2013-03-31 | -129.68% |
| 2012-12-31 | -259.24% |
| 2012-09-30 | -226.47% |
| 2012-06-30 | -246.32% |
| 2012-03-31 | -261.82% |
| 2011-12-31 | -118.32% |
| 2011-09-30 | -76.40% |
| 2011-06-30 | -132.26% |
| 2011-03-31 | -119.88% |
| 2010-12-31 | -160.53% |
| 2010-09-30 | -88.53% |
| 2010-06-30 | -213.15% |
| 2009-06-30 | -570.25% |
| 2009-03-31 | -104.95% |
| 2008-12-31 | -67.26% |
| 2008-09-30 | -22.95% |
| 2008-06-30 | -28.10% |
| 2008-03-31 | -22.36% |
| 2007-12-31 | -22.30% |
| 2007-09-30 | -58.39% |
| 2007-06-30 | -163.64% |
| 2007-03-31 | -135.28% |
| 2006-12-31 | -135.32% |
| 2006-09-30 | -75.43% |
| 2006-06-30 | -30.78% |
| 2006-03-31 | -23.57% |
| 2005-12-31 | -22.50% |
| 2005-09-30 | -39.01% |
| 2005-06-30 | -58.82% |
| 2005-03-31 | -56.36% |
| 2004-12-31 | -48.13% |
| 2004-09-30 | -82.07% |
| 2004-06-30 | -63.74% |
| 2004-03-31 | -55.69% |
| 2003-12-31 | -103.69% |
| 2003-09-30 | -78.66% |
| 2003-06-30 | -57.24% |
